Clinical Trial Update: Clinical Trial of Stem Cell Based Tissue Engineered Laryngeal Implants [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of stem cell–based tissue-engineered laryngeal implants sponsored by University College London has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngostenosis
• Tracheal Stenosis
• Upper Respiratory Tract Disorders

Snippet

Sponsor: University College, London | Conditions: Disorder of Upper Respiratory System, Laryngostenosis | Phase 1, Phase 2 | Status: WITHDRAWN